Timothy McKinney
Turnersville, NJNPI 1093741597
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (55.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Olympus Winter & Ibe GmbH at 55.4% of the total. Reporting peaked in 2021 at $1,104,555 and has fallen 97.8% since, to $24,273 in 2024.
Across 38 payments — averaging $46,561 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Winter & Ibe GmbH$981K
- Laborie Medical Technologies Corp.$788K
- Medtronic$313
- Clinical Innovations, LLC$106
- KCI USA, Inc.$73
- AbbVie$20
What the payments were for
- Consulting fees$160,0009%
- Speaking & faculty fees$627,69235%
- Food & beverage$6330%
- Other$981,01055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Winter & Ibe GmbH | 2 | $981,010 |
| Laborie Medical Technologies Corp. | 29 | $787,814 |
| Medtronic | 4 | $313 |
| Clinical Innovations, LLC | 1 | $106 |
| KCI USA, Inc. | 1 | $73 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$124
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.